Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,724 | -5,339 | -9,926 | -19,322 | -9,738 |
| Depreciation Amortization | -2,218 | 111 | 114 | 91 | 93 |
| Accounts payable and accrued liabilities | 3,462 | 28 | -783 | -411 | 1,101 |
| Other Working Capital | 11,591 | -472 | -1,661 | -28 | 1,877 |
| Other Operating Activity | 13,052 | 658 | 1,344 | 908 | -1,058 |
| Operating Cash Flow | $-57,837 | $-5,014 | $-10,912 | $-18,762 | $-7,725 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -189 | N/A | -2 | -43 | -19 |
| Purchase Of Investment | -329,938 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-330,127 | $N/A | $-2 | $-43 | $-19 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,980 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 54 | N/A | N/A | 24,070 | 50,894 |
| Other Financing Activity | 424,505 | 0 | 0 | -977 | -2,442 |
| Financing Cash Flow | $449,539 | $N/A | $N/A | $23,093 | $48,452 |
| Beginning Cash Position | N/A | 42,445 | 53,359 | 49,071 | 8,363 |
| End Cash Position | 61,575 | 37,431 | 42,445 | 53,359 | 49,071 |
| Net Cash Flow | $61,575 | $-5,014 | $-10,914 | $4,288 | $40,708 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,837 | -5,014 | -10,912 | -18,762 | -7,725 |
| Capital Expenditure | -189 | N/A | -2 | -43 | -19 |
| Free Cash Flow | -58,026 | -5,014 | -10,914 | -18,805 | -7,744 |